iPSCs: A powerful tool for skeletal muscle tissue engineering.

Area of Science:

• Regenerative Medicine
• Biotechnology
• Biomaterials Science

Background:

• Volumetric muscle loss (VML) and degenerative diseases cause significant skeletal muscle mass reduction, lacking optimal treatments.
• Tissue engineering presents promising strategies to address skeletal muscle deficits.
• Induced pluripotent stem cells (iPSCs) offer revolutionary potential for personalized medicine applications.

Purpose of the Study:

• To provide a comprehensive overview of skeletal muscle tissue engineering using iPSCs.
• To outline key considerations for developing effective skeletal muscle regeneration strategies.
• To highlight the integration of scaffold design, cell sourcing, and biochemical factors.

Main Methods:

• Review of current literature on skeletal muscle tissue engineering and iPSC applications.
• Analysis of essential components for successful skeletal muscle regeneration: scaffolds, cell sources, and bioactive factors.
• Focus on the three core pillars of tissue engineering: scaffold design, cell selection, and enhancement factors.

Main Results:

• iPSCs present a viable cell source for skeletal muscle tissue engineering due to their regenerative potential.
• Scaffold design is crucial for providing structural support and guiding tissue formation.
• Optimizing cell source selection and incorporating specific factors can enhance functional tissue development.

Conclusions:

• Skeletal muscle tissue engineering with iPSCs holds significant promise for treating muscle loss conditions.
• A multidisciplinary approach integrating biomaterials, cell biology, and developmental cues is essential.
• Further research into scaffold optimization, cell differentiation, and functional integration is warranted for clinical translation.